info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
United States Flag  US: +1-315-636-4233    United Kingdom Flag  UK: +44-162-237-0614    Indian Flag  IN: +91-826-083-6500
smrlogonew
  • Home
  • About
    • Why SMR
    • Research Methodology
    • Media Coverage
    • Join Our Team
  • Reports
    • Aerospace and Defense
    • Agriculture
    • Automotive
    • Chemicals and Materials
    • Consumer Goods
    • Energy and Power
    • Equipment and Machinery
    • Food and Beverages
    • Healthcare
    • Information and Communication Technology
    • Semiconductor and Electronics
    • Manufacturing and Construction
  • Our Practices
    • Syndicated Research
    • Consulting Services
    • Custom Research
    • Full-time Engagement Model
  • Insights
    • Press Release
    • Blog
  • Contact
Home » Healthcare

Healthcare

Transfusion Medicine Market By Product Type (Blood Components & Derivatives [Whole Blood; Red Blood Cells (RBCs); Plasma; Platelets; Cryoprecipitate; Granulocytes]; Reagents & Consumables [Blood Grouping Reagents; Antibody Screening Reagents; Hematology Reagents; Coagulation Reagents; Immunohematology Reagents; Others]; Instruments & Devices [Blood Collection Devices; Blood Processing Devices; Blood Storage & Transportation Devices; Blood Screening & Diagnostic Devices]; Software & IT Solutions [Blood Bank Management Software; Laboratory Information Systems (LIS); Donor & Inventory Management Systems]); By Application (Blood Transfusion & Therapy; Blood Screening & Testing; Cell Therapy & Regenerative Medicine; Other Specialized Applications); By End-User (Blood Banks & Transfusion Centers; Hospitals & Clinics; Diagnostic & Research Laboratories; Academic & Research Institutions; Pharmaceutical & Biotechnology Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Transfusion Medicine Market Size & Overview

The Transfusion Medicine Market was valued at $61.2 billion in 2024 and is projected to reach $88.8 billion by 2030, expanding at a CAGR of 6.4%. This growth is driven by the increasing demand for blood products, technol... Read More

Published Date: MAR-2025 | No Of Pages:150 | $ 4485

Liquid Filled Hard Capsules Market By Product Type (Softgel Capsules; Hard Gelatin Capsules); By Drug Class (Omega-3 Fatty Acids; Antihypertensive Drugs; Cholesterol-Lowering Agents; Anticoagulants; Cardioprotective Nutraceuticals); By Application (Cardiovascular Disease Prevention; Hypertension Management; Cholesterol & Lipid Regulation; Arrhythmia Treatment; Heart Failure Support); By Distribution Channel (Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Specialty Clinics); By End-User (Hospitals; Cardiac Care Centers; Ambulatory Surgical Centers; Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Liquid Filled Hard Capsules Market Size & Overview

The Liquid Filled Hard Capsules Market was valued at $1,023.50 million in 2024 and is projected to reach $1,486.51 million by 2030, growing at a CAGR of 6.21% during the forecast period. The market expansion is pr... Read More

Published Date: MAR-2025 | No Of Pages:150 | $ 4485

Heart Defects Closure Device Market By Product Type (Atrial Septal Defect [ASD] Closure Devices; Patent Foramen Ovale [PFO] Closure Devices; Ventricular Septal Defect [VSD] Closure Devices; Left Atrial Appendage [LAA] Closure Devices; Patent Ductus Arteriosus [PDA] Closure Devices); By Material Type (Nitinol-based Closure Devices; Bioabsorbable Closure Devices; Titanium-based Closure Devices; Other Materials); By End-User (Hospitals; Ambulatory Surgical Centers [ASCs]; Cardiac Catheterization Labs; Specialty Clinics); By Age Group (Pediatric Patients; Adult Patients); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Heart Defects Closure Device Market Size & Overview

The Heart Defects Closure Device Market was valued at approximately $3.5 billion in 2024 and is projected to reach $6.8 billion by 2030, growing at a CAGR of 9.2% during the forecast period. The market is driven ... Read More

Published Date: MAR-2025 | No Of Pages:150 | $ 4485

Tricuspid Valve Repair Market By Product Type (Annuloplasty Rings; Transcatheter Tricuspid Valve Repair Devices; Surgical Tricuspid Valve Repair Systems); By Procedure Type (Open-Heart Surgery; Minimally Invasive Surgery; Transcatheter Tricuspid Valve Repair [TTVR]); By Indication (Tricuspid Regurgitation [TR]; Tricuspid Stenosis; Congenital Heart Defects; Functional Tricuspid Valve Disease); By End-User (Hospitals; Ambulatory Surgical Centers [ASCs]; Specialty Cardiac Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Tricuspid Valve Repair Market Size & Overview

The Tricuspid Valve Repair Market was valued at approximately $723.1 million in 2024 and is projected to reach $1.04 billion by 2030, growing at a CAGR of 6.2% during the forecast period. The market is driven by the gr... Read More

Published Date: MAR-2025 | No Of Pages:150 | $ 4485

Surgical Sealants and Adhesives Market By Product Type (Natural Sealants & Adhesives [Fibrin-based Sealants; Collagen-based Sealants; Albumin-based Sealants]; Synthetic & Semi-Synthetic Sealants & Adhesives [Polyethylene Glycol (PEG)-based Sealants; Cyanoacrylate-based Adhesives; Polyurethane-based Sealants]); By Indication (Surgical Hemostasis; Tissue Sealing; Tissue Engineering); By Application (General Surgery; Cardiovascular Surgery; Orthopedic Surgery; Neurological Surgery; Pulmonary Surgery; Urological Surgery; Cosmetic & Reconstructive Surgery; Others); By End-User (Hospitals; Ambulatory Surgical Centers [ASCs]; Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Surgical Sealants And Adhesives Market Size & Overview

The Surgical Sealants and Adhesives Market was valued at $2.7 billion in 2024 and is projected to reach $4.6 billion by 2030, growing at a CAGR of 8.2% during the forecast period. The market is driven by the i... Read More

Published Date: MAR-2025 | No Of Pages:150 | $ 4485

Remote Cardiac Monitoring Market By Device Type (ECG Monitoring Devices; Implantable Loop Recorders [ILRs]; Holter Monitors; Cardiac Event Monitors; Mobile Cardiac Telemetry [MCT]; Smart Wearables [Smartwatches, Patches]); By Technology (Wireless Communication; Bluetooth-enabled Devices; AI-powered Monitoring Systems; Cloud-based Monitoring); By Application (Atrial Fibrillation Monitoring; Arrhythmia Detection & Management; Heart Failure Monitoring; Ischemic Heart Disease Monitoring; Hypertension Management); By End-User (Hospitals & Clinics; Home Healthcare Settings; Ambulatory Surgical Centers [ASCs]; Cardiac Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Remote Cardiac Monitoring Market Size & Overview

The Remote Cardiac Monitoring Market was valued at $5.4 billion in 2024 and is projected to reach $12.1 billion by 2030, growing at a CAGR of 14.2% during the forecast period. This growth is propelled by the rising ... Read More

Published Date: MAR-2025 | No Of Pages:150 | $ 4485

Interventional Image Guided Systems Market By Modality (X-ray Fluoroscopy; Ultrasound; Magnetic Resonance Imaging [MRI]; Computed Tomography [CT]; Nuclear Imaging [PET/SPECT]); By Product Type (Fixed Interventional Systems; Mobile Interventional Systems; Portable Imaging Systems); By Application (Cardiology; Neurology; Oncology; Orthopedics; Gastroenterology; Urology; Others); By End-User (Hospitals; Ambulatory Surgical Centers [ASCs]; Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Interventional Image Guided Systems Market Size & Overview

The Interventional Image Guided Systems Market was valued at approximately $5.1 billion in 2024 and is projected to reach $7.4 billion by 2030, growing at a CAGR of 6.3% during the forecast period. This gr... Read More

Published Date: MAR-2025 | No Of Pages:150 | $ 4485

Embolic Protection Devices Market By Product Type (Distal Occlusion Devices; Distal Filters; Proximal Occlusion Devices); By Indication (Percutaneous Coronary Intervention [PCI]; Carotid Artery Stenting [CAS]; Transcatheter Aortic Valve Replacement [TAVR]; Saphenous Vein Graft [SVG] Interventions; Other Vascular Interventions); By Material (Polyurethane-based EPDs; Nitinol-based EPDs; Other Materials); By End-User (Hospitals; Specialty Cardiac Centers; Ambulatory Surgical Centers [ASCs]); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Embolic Protection Devices Market Size & Overview

The Embolic Protection Devices (EPDs) Market was valued at approximately $683.4 billion in 2024 and is projected to reach $1.1 billion by 2030, growing at a CAGR of 8.5% during the forecast period. The market is fu... Read More

Published Date: MAR-2025 | No Of Pages:150 | $ 4485

Antiarrhythmic Drugs Market By Drug Class (Class I [Sodium Channel Blockers: Quinidine, Procainamide, Lidocaine, Flecainide]; Class II [Beta Blockers: Propranolol, Esmolol, Metoprolol]; Class III [Potassium Channel Blockers: Amiodarone, Dronedarone, Sotalol]; Class IV [Calcium Channel Blockers: Verapamil, Diltiazem]; Others [Digoxin, Adenosine]); By Route of Administration (Oral; Intravenous [IV]); By Indication (Atrial Fibrillation [AF]; Supraventricular Tachycardia [SVT]; Ventricular Arrhythmias; Bradyarrhythmias; Others); By Distribution Channel (Hospital Pharmacies; Retail Pharmacies; Online Pharmacies); By End-User (Hospitals & Clinics; Ambulatory Surgical Centers [ASCs]; Cardiac Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Antiarrhythmic Drugs Market Size & Overview

The Antiarrhythmic Drugs Market was valued at $1.9 billion in 2024 and is projected to reach $2.8 billion by 2030, growing at a CAGR of 6.5% during the forecast period. The market is driven by the rising prevalence of at... Read More

Published Date: MAR-2025 | No Of Pages:150 | $ 4485

Structural Heart Devices Market By Product Type (Transcatheter Heart Valves; Surgical Heart Valves; Annuloplasty Rings; Occluders & Closure Devices; Accessories); By Procedure Type (Transcatheter Aortic Valve Replacement [TAVR]; Transcatheter Mitral Valve Repair [TMVR]; Surgical Aortic Valve Replacement [SAVR]; Left Atrial Appendage Closure [LAAC]; Septal Defect Closure); By Indication (Aortic Stenosis; Mitral Regurgitation; Atrial Septal Defects [ASD]; Patent Foramen Ovale [PFO]; Left Atrial Appendage Closure [LAAC]; Others); By End-User (Hospitals; Ambulatory Surgical Centers [ASCs]; Cardiac Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Structural Heart Devices Market Size & Overview

The Structural Heart Devices Market was valued at $14.4 billion in 2024 and is projected to reach $24.6 billion by 2030, growing at a CAGR of 9.3% during the forecast period. The market is driven by the increasing pr... Read More

Published Date: MAR-2025 | No Of Pages:150 | $ 4485
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Reports by Industry

  • Aerospace and Defense
  • Agriculture
  • Automotive
  • Chemicals and Materials
  • Consumer Goods
  • Energy and Power
  • Equipment and Machinery
  • Food and Beverages
  • Healthcare
  • Information and Communication Technology
  • Semiconductor and Electronics
  • Manufacturing and Construction

Trust Online

  • paypal.png
  • wiretransfers

Follow Us

  • facebook
  • twitter
  • instagram
  • linkedin

Contact Us

  • US: (+1) 315-636-4233
  • UK: (+44) 1622-370-614
  • IN: (+91) 826-083-6500
  • info@strategicmarketresearch.com
  • Strategic Market Research
    26, Broadway Suite 934, New York , 10004

Quick Link

  • Why SMR
  • Research Methodology
  • Media Coverage
  • Join Our Team
  • Press Release
  • Blog

Customer Support

  • FAQs
  • Contact
  • Terms of Use
  • Privacy Policy
  • Disclaimer Policy
  • Return Policy
Copyright © 2022 Strategic Market Research All rights reserved.